Zielinski, Christoph.
Zielinski, Christoph, 1952-
Christoph Zielinski Austrian physician and oncologist
Zielinski, Christoph C., 1952-
VIAF ID: 67958370 ( Personal )
Permalink: http://viaf.org/viaf/67958370
Preferred Forms
- 100 0 _ ‡a Christoph Zielinski ‡c Austrian physician and oncologist
- 100 1 _ ‡a Zielinski, Christoph
- 100 1 0 ‡a Zielinski, Christoph C., ‡d 1952-
- 100 1 _ ‡a Zielinski, Christoph ‡d 1952-
- 100 1 _ ‡a Zielinski, Christoph ‡d 1952-
-
-
4xx's: Alternate Name Forms (12)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Budget projections and clinical impact of an immuno-oncology class of treatments experience in four EU markets | |
Colorectales Carcinom | |
Consensus on medical treatment of non-small-cell lung cancer - update 2004 | |
Delay in time to worsening of symptoms (TWS) of advanced non-small cell lung cancer (NSCLC) using gemcitabine (gem) maintenance therapy | |
Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease | |
Gedichte zum Nachbeten | |
Gemcitabine and cisplatin (GC) +/- subsequent theapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): preliminary results of a randomized trial of the Central European cooperative | |
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer : a Central European cooperative oncology group international, multicenter, prospective, randomized phase III trial | |
The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients | |
Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy : a pooled analysis of three trials | |
Mammacarcinom | |
Medizin und Ihre Feinde Wie Scharlatane und Verschwörungstheoretiker seit Jahrhunderten Wissenschaft bekämpfen | |
Non-small cell lung cancer in countries of Central and Southeastern Europe: diagnostic procedures and treatment reimbursement surveyed by the Central European Cooperative Oncology Group | |
Perspectives for cancer care and research in Central and Eastern Europe | |
Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer results of the CECOG LaVie trial | |
Systemic lupus erythematosus, c1987: | |
Targeted Therapy beim Nierenzellkarzinom | |
Urogenitale Carcinome |